33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy
    Meeting Abstract

    Sadelain, M.; Condomines, M.; Zhao, Z.; Brentjens, R. J.; Riviere, I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Meta-analysis of stomatitis incidence in everolimus (EVE) clinical studies and its relationship with efficacy
    Meeting Abstract

    Rugo, H. S.; Yao, J. C.; Hortobagyi, G. N.; Pavel, M. E.; Franz, D. N.; Ravaud, A.; Taran, T.; Gallo, J.; Rouyrre, N.; Anak, O.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Meeting Abstract

    Rosenberg, J. E.; Van Allen, E. M.; Mouw, K. W.; Kim, P. H.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and response with nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus erlotinib in patients (pts) with epidermal growth factor receptor mutant (EGFR MT) advanced NSCLC
    Meeting Abstract

    Rizvi, N. A.; Chow, L. Q. M.; Borghaei, H.; Shen, Y.; Harbison, C.; Alaparthy, S.; Chen, A. C.; Gettinger, S. N.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical trials of MPDL3280A (anti-PDL1) in patients (pts) with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Chow, L. Q. M.; Dirix, L. Y.; Gettinger, S. N.; Gordon, M. S.; Kabbinavar, F. F.; Von Pawel, J.; Sorla, J. C.; Chappey, C.; Mokatrin, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Garon, E. B.; Patnaik, A.; Gandhi, L.; Leighl, N. B.; Balmanoukian, A. S.; Goldman, J. W.; Eder, J. P.; Johnson, E.; Blumenschein, G. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302
    Meeting Abstract

    Ricci, D. S.; Li, W. M.; Griffin, T. W.; Gormley, M.; Henitz, E.; Ryan, C. J.; de Bono, J. S.; Attard, G.; Van Den Eertwegh, A. J. M.; Schrijvers, D. L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)
    Meeting Abstract

    Ribas, A.; Hodi, F. S.; Kefford, R.; Hamid, O.; Daud, A.; Wolchok, J. D.; Hwu, W. J.; Gangadhar, T. C.; Patnaik, A.; Joshua, A. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 study of LJM716 in patients with esophageal squamous cell carcinoma, bead and neck cancer, or HER2-overexpressing metastatic breast or gastric cancer
    Meeting Abstract

    Reynolds, K. L.; Juric, D.; Baselga, J.; Alsina, M.; Tabernero, J.; Bedard, P. L.; Graham, D. M.; Gonzalez-Angulo, A. M.; Garrido-Laguna, I.; Sharma, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save